Titan Medical Confirms Receipt of Deficiency Notice From Nasdaq
TORONTO–(BUSINESS WIRE)–Titan Medical Inc. (Titan or the Company) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, today announced that on August 5, 2020, the Company received a deficiency notice from the Nasdaq Stock Market LLC (Nasdaq) Listing Qualifications Department that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Rule 5550(a)(2) since the closing bid price for the …
